Trial intelligence / Profile preview

Furosemide Stress Test for Renal Recovery in AKI

NCT02800135Terminated

Sponsor
CHU Saint-Etienne
Start
Apr 2016
Primary completion
Mar 2018
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of furosemide in acute kidney injury (AKI), sponsored by CHU Saint-Etienne. Primary endpoint: Number of patients with renal recovery at Day 3. Started Apr 2016; status: terminated.

02

Drugs

furosemide
03

Conditions

acute kidney injury (AKI)

Beyond the preview

Go deeper on NCT02800135.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02800135.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call